Company to buy
- Size: Mid-size business
- Revenue: 2-20 M EUR
- Location of the target company: Europe
- CFIE PHB329
Overview of buyer for early-stage Contract Research Organisation in Europe
A globally recognized specialist Contract Research Organization (CRO) is seeking to expand through the acquisition of early-stage CROs in Europe. As the world leader in human challenge trials, this organization focuses on testing infectious and respiratory disease vaccines and therapeutics, providing end-to-end early clinical development services to a diverse, international client base of pharmaceutical and biotechnology companies.
Profile of buyer for early-stage Contract Research Organisation in Europe
With a rich legacy of over two decades in conducting human challenge studies, the company has built a reputation for scientific excellence and operational innovation. It operates from multiple state-of-the-art facilities designed to deliver high-quality, compliant, and efficient clinical trial experiences. The organization’s mission is to empower innovation in healthcare and transform the drug development process through cutting-edge science and a future-focused vision.
Contact us to get details about this buyer for early-stage Contract Research Organisation in Europe
Activity and Products of buyer for early-stage Contract Research Organisation in Europe
This CRO specializes in human challenge trials across a portfolio of 11+ challenge models including Influenza, RSV, HRV, Asthma, Cough, COPD, COVID-19, hMPV, and Malaria. It offers full-spectrum services tailored to the needs of pharmaceutical and biotech sponsors, ensuring strategic and effective early-phase clinical development. Additionally, the company operates a highly specialized virology and immunology laboratory that supports both pre-clinical and clinical respiratory drug and vaccine development. Its labs deliver precise, submission-ready data supported by rigorous scientific and quality standards.
Highlights of buyer for early-stage Contract Research Organisation in Europe
- Global leader in human challenge trial research with over 25 years of experience
- Operates the largest dedicated human challenge trial facility in the world, equipped with advanced laboratories and high-capacity quarantine units
- Offers a broad range of challenge study models and laboratory services, supporting diverse clinical and pre-clinical development needs
- Maintains multiple strategically located screening and recruitment sites for optimized participant enrollment
- Backed by a team of highly skilled scientists and clinicians, underpinned by a mission to revolutionize healthcare through scientific ingenuity
More information on this buyer for early-stage Contract Research Organisation in Europe
Please get in touch if you are interested in learning more about this buyer for early-stage Contract Research Organisation in Europe. For more cro companies for sale please visit the section cro companies for sale. For other cro buyers, please visit the section cro companies wanted. If you are instead interested in pharma companies for sale, please visit the pharma companies for sale section. For pharma buyers, please visit the section pharma companies wanted.
Subscribe as a seller for this CRO buyer
Note: CFIE only works with formal companies. We do get a lot of requests and it is difficult to follow up on all inquiries from visitors to our website. For each company, we assess the likelihood of a future transaction. We only get back to you if we see a real opportunity to do a future acquisition or business sale. In order to increase your chances of receiving a reply as an individual, please explain as much as possible about your personal background, strategy, and fit with the target. There is also a possibility that your details will be kept on file, and we will get back to you once there is an opportunity to do a transaction. CFIE cannot guarantee you will receive an answer to your request.